These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 364545

  • 1. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
    Whittle BJ, Moncada S, Vane JR.
    Prostaglandins; 1978 Sep; 16(3):373-88. PubMed ID: 364545
    [Abstract] [Full Text] [Related]

  • 2. The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time.
    Ubatuba FB, Moncada S, Vane JR.
    Thromb Haemost; 1979 Apr 23; 41(2):425-35. PubMed ID: 382434
    [Abstract] [Full Text] [Related]

  • 3. Some actions of prostacyclin (PGI2) on the cardiovascular system and the gastric microcirculation.
    Whittle BJ, Moncada S, Vane JR.
    Acta Biol Med Ger; 1978 Apr 23; 37(5-6):725-8. PubMed ID: 369255
    [Abstract] [Full Text] [Related]

  • 4. Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue.
    Whittle BJ, Moncada S, Mullane K, Vane JR.
    Prostaglandins; 1983 Feb 23; 25(2):205-23. PubMed ID: 6344147
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
    Nakagawa S, Matsui N, Akiba T, Shinoda T, Fukudome Y, Ozawa K, Baba M, Nakanishi T, Takeuchi J.
    Proc Eur Dial Transplant Assoc; 1981 Feb 23; 18():117-21. PubMed ID: 7036145
    [Abstract] [Full Text] [Related]

  • 6. Prostaglandin releasing polymers - stability and efficacy.
    McRea JC, Ebert CD, Kim SW.
    Trans Am Soc Artif Intern Organs; 1981 Feb 23; 27():511-6. PubMed ID: 7036503
    [Abstract] [Full Text] [Related]

  • 7. Anti-aggregatory effect of prostacyclin (PGI2) in vivo.
    Bayer BL, Blass KE, Förster W.
    Br J Pharmacol; 1979 May 23; 66(1):10-2. PubMed ID: 378308
    [Abstract] [Full Text] [Related]

  • 8. 6-Keto-prostaglandin E1 inhibits the aggregation of human platelets.
    Wong PY, McGiff JC, Sun FF, Lee WH.
    Eur J Pharmacol; 1979 Dec 07; 60(2-3):245-8. PubMed ID: 393526
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prostaglandins and platelet aggregation.
    Smith JB.
    Acta Med Scand Suppl; 1981 Dec 07; 651():91-9. PubMed ID: 7034481
    [Abstract] [Full Text] [Related]

  • 12. Refractoriness of diabetic platelets to inhibitory prostaglandins.
    Lagarde M, Berciaud P, Burtin M, Dechavanne M.
    Prostaglandins Med; 1981 Oct 07; 7(4):341-7. PubMed ID: 6273957
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prostaglandins as inhibitors of human platelet aggregation.
    Di Minno G, Silver MJ, de Gaetano G.
    Br J Haematol; 1979 Dec 07; 43(4):637-47. PubMed ID: 393296
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.